Andrea James
Chief Financial Officer
Replay available
Insight Molecular Diagnostics Inc. (IMDX) Q1 2026 Earnings Call
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Josh Riggs
President and Chief Executive Officer
Thomas Flatton
Analyst, Lake Street
Mason Carrico
Analyst, Stevens
Mike Mattson
Analyst, Needham
Mark Massaro
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Insight Molecular Diagnostics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.617 Welcome, everyone, and thank you for joining us to discuss Insight Molecular Diagnostics 00:00:05.617 -- 00:00:08.958 first quarter 2026 results. 00:00:09.200 -- 00:00:14.606 If you have not seen today's shareholder letter, please visit Insight Molecular Diagnostics 00:00:14.606 -- 00:00:19.509 Investors Relations page at investors.imdxinc.com. 00:00:22.754 -- 00:00:27.740 Today's prepared remarks build upon the information already shared in this robust letter. 00:00:27.740 -- 00:00:33.467 Joining us today are Insight Molecular Diagnostics President and CEO Josh Riggs, 00:00:33.467 -- 00:00:39.275 Chief Science Officer Eki Schutz, and CFO Andrea James. 00:00:39.275 -- 00:00:42.699 We also have our analysts with us as panelists. 00:00:42.699 -- 00:00:47.065 After our prepared remarks, our analysts may ask questions. 00:00:47.065 -- 00:00:51.668 Before turning the call over to Josh Riggs, I'd like to go over our safe harbor. 00:00:51.668 -- 00:00:56.483 The company will make projections and forward-looking statements regarding future events. 00:00:56.483 -- 00:01:00.562 Any statements that are not historical facts are forward-looking statements. 00:01:00.562 -- 00:01:05.871 These statements are made pursuant to and within the meaning of the safe harbor provision 00:01:05.871 -- 00:01:10.038 of the Private Securities Litigation Reform Act of 1995. 00:01:10.038 -- 00:01:14.966 We encourage you to review the company's SEC filings, including the company's most recent 00:01:14.966 -- 00:01:20.135 Form 10-K and subsequent Forms 10-Q, which identify risks and 00:01:20.135 -- 00:01:25.183 uncertainties that may cause future actual results or events to differ 00:01:25.183 -- 00:01:30.391 materially. Please note that the forward-looking statem...